Developments in clinical cell therapy

David Stroncek; Deborah Berlyne; Bernard Fox; Adrian Gee; Shelly Heimfeld; Robert Lindblad; Kathy Loper; David H McKenna; Cliona Rooney; Marianna Sabatino; Elizabeth Wagner; Theresa Whiteside; Deborah Wood; Traci Heath-Mondoro

doi:10.3109/14653240903511952

Developments in clinical cell therapy

David Stroncek, Deborah Berlyne, Bernard Fox, Adrian Gee, Shelly Heimfeld, Robert Lindblad, Kathy Loper, David H McKenna, Cliona Rooney, Marianna Sabatino, Elizabeth Wagner, Theresa Whiteside, Deborah Wood, Traci Heath-Mondoro

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23-24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.

Original language	English (US)
Pages (from-to)	425-428
Number of pages	4
Journal	Cytotherapy
Volume	12
Issue number	3
DOIs	https://doi.org/10.3109/14653240903511952
State	Published - 2010

Bibliographical note

Funding Information:
The workshop planning committee wishes to thank the speakers and moderators for their participation in the workshop and their contributions to this article. This project was supported with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services under contract numbers N01-HB-37163, N01-HB-37164, N01-HB-37165 and N01-HB-37166.

Keywords

Cancer
Cell therapy
Hematopoietic stem cell transplantation
Regenerative medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.3109/14653240903511952

Find It

Find It at U of M Libraries

Cite this

@article{9c00141802a8438c93e260e42167020a,

title = "Developments in clinical cell therapy",

abstract = "Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23-24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.",

keywords = "Cancer, Cell therapy, Hematopoietic stem cell transplantation, Regenerative medicine",

author = "David Stroncek and Deborah Berlyne and Bernard Fox and Adrian Gee and Shelly Heimfeld and Robert Lindblad and Kathy Loper and McKenna, {David H} and Cliona Rooney and Marianna Sabatino and Elizabeth Wagner and Theresa Whiteside and Deborah Wood and Traci Heath-Mondoro",

note = "Funding Information: The workshop planning committee wishes to thank the speakers and moderators for their participation in the workshop and their contributions to this article. This project was supported with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services under contract numbers N01-HB-37163, N01-HB-37164, N01-HB-37165 and N01-HB-37166. ",

year = "2010",

doi = "10.3109/14653240903511952",

language = "English (US)",

volume = "12",

pages = "425--428",

journal = "Cytotherapy",

issn = "1465-3249",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Developments in clinical cell therapy

AU - Stroncek, David

AU - Berlyne, Deborah

AU - Fox, Bernard

AU - Gee, Adrian

AU - Heimfeld, Shelly

AU - Lindblad, Robert

AU - Loper, Kathy

AU - McKenna, David H

AU - Rooney, Cliona

AU - Sabatino, Marianna

AU - Wagner, Elizabeth

AU - Whiteside, Theresa

AU - Wood, Deborah

AU - Heath-Mondoro, Traci

N1 - Funding Information: The workshop planning committee wishes to thank the speakers and moderators for their participation in the workshop and their contributions to this article. This project was supported with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services under contract numbers N01-HB-37163, N01-HB-37164, N01-HB-37165 and N01-HB-37166.

PY - 2010

Y1 - 2010

N2 - Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23-24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.

AB - Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23-24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.

KW - Cancer

KW - Cell therapy

KW - Hematopoietic stem cell transplantation

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=77950550602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950550602&partnerID=8YFLogxK

U2 - 10.3109/14653240903511952

DO - 10.3109/14653240903511952

M3 - Article

C2 - 20078383

AN - SCOPUS:77950550602

SN - 1465-3249

VL - 12

SP - 425

EP - 428

JO - Cytotherapy

JF - Cytotherapy

IS - 3

ER -

Developments in clinical cell therapy

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this